CovidResearchTrials by Shray Alag


CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)


Biological testWiki

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (2)


Name (Synonyms) Correlation
drug682 Ravulizumab Wiki 1.00
drug114 Best Supportive Care Wiki 1.00

Correlated MeSH Terms (7)


Name (Synonyms) Correlation
D055370 Lung Injury NIH 0.32
D011024 Pneumonia, Viral NIH 0.17
D055371 Acute Lung Injury NIH 0.16
D013577 Syndrome NIH 0.15
D012127 Respiratory Distress Syndrome, Newborn NIH 0.15
D012128 Respiratory Distress Syndrome, Adult NIH 0.13
D011014 Pneumonia NIH 0.08

Correlated HPO Terms (0)


Name (Synonyms) Correlation

There is one clinical trial.

Clinical Trials


1 Cohort of Patients With Covid19: Constitution of Blood Samples Collections With Clinical Characterization

Biological collection (blood sample) associated with clinical data from Covid-19 patients

NCT04363385 Covid-19 Biological: Biological test

Primary Outcomes

Description: Clinical aggravation markers (admission in intensive care)

Measure: Phenotype/genotype correlation research modulating the severity of Covid-19 disease

Time: Anytime in the period of 10 years

Secondary Outcomes

Description: Severity at the Covid-19 Lung Scanner

Measure: Phenotype/transcriptomic correlation research modulating the severity of Covid-19 disease

Time: Anytime in the period of 10 years

Description: Severity at the Covid-19 Lung Scanner

Measure: Phenotype/biomarker correlation research modulating the severity of Covid-19 disease

Time: Anytime in the period of 10 years

Description: Evolution of scanographic lesions or pulmonary ultrasound

Measure: Development of clinical-biological scores in the severity of Covid-19 disease

Time: Anytime in the period of 10 years

Description: Evolution of scanographic lesions or pulmonary ultrasound

Measure: Development of predictive imaging scores in the severity of Covid-19 disease

Time: Anytime in the period of 10 years

Description: Duration of oxygen therapy, artificial ventilation

Measure: Identification of pathophysiological pathways to susceptibility to Covid-19 disease

Time: Anytime in the period of 10 years

Description: Genome sequencing

Measure: Identification of genetic markers for treatment response

Time: Anytime in the period of 10 years

Description: Sequencing transcriptome

Measure: Identification of transcriptomic markers for treatment response

Time: Anytime in the period of 10 years

Description: Proteomic sequencing

Measure: Identification of proteomic for treatment response

Time: Anytime in the period of 10 years


No related HPO nodes (Using clinical trials)